Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 444, 796-797 (14 December 2006) | doi:10.1038/444796a; Published online 13 December 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
CERC in Developmental Immunology and Immunosenescence
- Dalhousie University
- Halifax, Nova Scotia
Postdoctoral Position in Cystic Fibrosis / Pulmonary Research
- Universitatsklinikum Heidelberg
- Heidelberg 69120 Germany
Agency set up to tackle bioterror
Meredith Wadman
Abstract
Last minute deals in Congress push through biodefence bill and give cash boost to NIH.
In a late-night flurry of activity as it rushed to adjourn, the US Congress last week created a new agency that will allocate $1 billion to companies that are developing drugs and vaccines to tackle bioterror and pandemic agents. Bleary-eyed lawmakers also passed legislation governing the broad workings of the National Institutes of Health (NIH) and authorizing a hefty budget boost for the biomedical agency over the next two years.
To read this story in full you will need to login or make a payment (see right).
